- Signaling Pathways
- Metabolic Enzyme/Protease
- Factor VIIa
Factor VIIa
Factor VIIa
- [1]. Chatterjee A, et al. Beyond coagulation: Coagulation protease factor VIIa in cytoprotective response. Int Immunopharmacol. 2025 Mar 26;150:114218. [Content Brief]
- [2]. Persson E, et al. Allosteric activation of coagulation factor VIIa. Front Biosci (Landmark Ed). 2011 Jun 1;16(8):3156-63. [Content Brief]
All Product Categories
-
Factor VIIa Related Products (7)
-
PCI-27483
0 ImagesPCI-27483 is a FVIIa/tissue factor inhibitor, with antitumour effects. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
ARC19499 sodium
0 ImagesCat. No.: HY-153480APurity: 99.40%Synonyms: BAX499 sodiumARC19499 sodium is an aptamer that inhibits tissue factor pathway inhibitor (TFPI) , thereby enabling clot initiation and propagation via the extrinsic pathway. The core aptamer binds tightly and specifically to TFPI. ARC19499 sodium blocks TFPI inhibition of both factor Xa and the TF/factor VIIa complex. ARC19499 sodium corrects thrombin generation in hemophilia A and B plasma and restores clotting in FVIII-neutralized whole blood. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
BMS-593214
0 ImagesBMS-593214 is an active site-directed factor (F) VIIa inhibitor. BMS-593214 shows antithrombotic and antihaemostatic properties. BMS-593214 is a direct competitive inhibitor of human FVIIa and a non-competitive inhibitor of Viia-activated substrate FX. BMS-593214 prevents electroinduced carotid artery thrombosis (AT) and wire induced vena cava thrombosis (VT). -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
ARC19499
0 ImagesCat. No.: HY-153480CAS No.: 1350667-54-7Synonyms: BAX499ARC19499 is an aptamer that inhibits tissue factor pathway inhibitor (TFPI) , thereby enabling clot initiation and propagation via the extrinsic pathway. The core aptamer binds tightly and specifically to TFPI. ARC19499 blocks TFPI inhibition of both factor Xa and the TF/factor VIIa complex. ARC19499 corrects thrombin generation in hemophilia A and B plasma and restores clotting in FVIII-neutralized whole blood. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
E-76
0 ImagesCat. No.: HY-P3235CAS No.: 1926163-13-4E-76 is a peptide with anticoagulant activity. E-76 inhibits blood coagulation by specifically binding to exogenous coagulation factor VIIa (FVIIa). E-76 can be used to study blood coagulation-related diseases. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
Vatreptacog alfa
0 ImagesCat. No.: HY-P992152Vatreptacog alfa is a recombinant hFVIIa analog, differing from native FVIIa by three amino acid substitutions (V158D, E296V and M298Q) in the protease domain. Vatreptacog alfa exhibits enhanced tissue factor-independent enzymatic activity toward activated platelets. Vatreptacog alfa can be used in the research of hemophilia. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -
-
ARC19499 sodium scrambled negative control
0 ImagesCat. No.: HY-153480CARC19499 sodium scrambled negative control is the sequence scrambled negative control of ARC19499 sodium. -
loading...Please select quantityGet Quote
August 31
-
Please select quantity
August 31
Get Quote
loading... -